These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 19228855)
1. Sex differences in the use of intravenous rt-PA thrombolysis treatment for acute ischemic stroke: a meta-analysis. Reeves M; Bhatt A; Jajou P; Brown M; Lisabeth L Stroke; 2009 May; 40(5):1743-9. PubMed ID: 19228855 [TBL] [Abstract][Full Text] [Related]
2. US geographic distribution of rt-PA utilization by hospital for acute ischemic stroke. Kleindorfer D; Xu Y; Moomaw CJ; Khatri P; Adeoye O; Hornung R Stroke; 2009 Nov; 40(11):3580-4. PubMed ID: 19797701 [TBL] [Abstract][Full Text] [Related]
3. The metabolic syndrome is associated with a higher resistance to intravenous thrombolysis for acute ischemic stroke in women than in men. Arenillas JF; Sandoval P; Pérez de la Ossa N; Millán M; Guerrero C; Escudero D; Dorado L; López-Cancio E; Castillo J; Dávalos A Stroke; 2009 Feb; 40(2):344-9. PubMed ID: 19109538 [TBL] [Abstract][Full Text] [Related]
4. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke? Hassan AE; Chaudhry SA; Jani V; Grigoryan M; Khan AA; Adil MM; Qureshi AI J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555 [TBL] [Abstract][Full Text] [Related]
5. IV tissue plasminogen activator use in acute stroke: experience from a statewide registry. Deng YZ; Reeves MJ; Jacobs BS; Birbeck GL; Kothari RU; Hickenbottom SL; Mullard AJ; Wehner S; Maddox K; Majid A; Neurology; 2006 Feb; 66(3):306-12. PubMed ID: 16476927 [TBL] [Abstract][Full Text] [Related]
6. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry. Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcome as function of blood pressure in acute ischemic stroke and effects of thrombolysis. Yong M; Diener HC; Kaste M; Mau J Cerebrovasc Dis; 2007; 24(4):349-54. PubMed ID: 17690547 [TBL] [Abstract][Full Text] [Related]
8. Current status of intravenous thrombolysis for acute ischemic stroke in Asia. Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797 [TBL] [Abstract][Full Text] [Related]
10. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry. Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333 [TBL] [Abstract][Full Text] [Related]
11. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152 [TBL] [Abstract][Full Text] [Related]
12. Factors associated with the administration of tissue plasminogen activator for acute ischemic stroke. Kunisawa S; Kobayashi D; Lee J; Otsubo T; Ikai H; Yokota C; Minematsu K; Imanaka Y J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):724-31. PubMed ID: 23910512 [TBL] [Abstract][Full Text] [Related]
13. Sex differences in IV thrombolysis treatment for acute ischemic stroke: A systematic review and meta-analysis. Strong B; Lisabeth LD; Reeves M Neurology; 2020 Jul; 95(1):e11-e22. PubMed ID: 32522796 [TBL] [Abstract][Full Text] [Related]
14. Unequal access to treatment with intravenous alteplase for women with acute ischemic stroke. de Ridder I; Dirks M; Niessen L; Dippel D; Stroke; 2013 Sep; 44(9):2610-2. PubMed ID: 23887843 [TBL] [Abstract][Full Text] [Related]
15. Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation. Lawson TR; Brown IE; Westerkam DL; Blackhurst DW; Sternberg S; Leacock R; Nathaniel TI Restor Neurol Neurosci; 2015; 33(3):301-8. PubMed ID: 25698111 [TBL] [Abstract][Full Text] [Related]
16. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences? Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959 [TBL] [Abstract][Full Text] [Related]
17. United States trends in thrombolysis for older adults with acute ischemic stroke. George BP; Asemota AO; Dorsey ER; Haider AH; Smart BJ; Urrutia VC; Schneider EB Clin Neurol Neurosurg; 2015 Dec; 139():16-23. PubMed ID: 26363362 [TBL] [Abstract][Full Text] [Related]
18. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals. Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398 [TBL] [Abstract][Full Text] [Related]
19. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China. Yan X; Hu HT; Liu S; Sun YH; Gao X Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471 [TBL] [Abstract][Full Text] [Related]